DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claim Interpretation
The following is a quotation of 35 U.S.C. 112(f):
(f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof.
The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph:
An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof.
The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked.
As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph:
(A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function;
(B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and
(C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function.
Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function.
Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function.
Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action.
Claim Rejections - 35 USC § 102
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 1-4, 7-9, 11-13, 17-19, and 21 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Sganga et al. (US 2021/0393333, hereinafter “Sganga”).
Referring to claim 1, Sganga discloses a method (Figs. 1, 8A, and 9A. The entire reference is applied to the rejection) comprising: obtaining, by a trained system, at least one movement command for an intervention device of a robotic surgical system to a location within a patient; determining, by the trained system, at least one actuator command for the robotic surgical system associated with the at least one movement command based on the movement command and an estimated current position of the intervention device; and applying the actuator command to the robotic surgical system (¶¶ [0006], [0011]-[0013], [0107][0108], and [0176], “Systems, methods, and devices for guiding an instrument within a vascular network of a patient are described herein. In some embodiments, the instrument comprises an endovascular or intraluminal instrument configured for navigation through the vascular network, such as a catheter (including a steerable or articulating catheter), guidewire, sheath, etc. In some embodiments, the instrument is coupled to a robotic medical system that is configured to manipulate the instrument (e.g., cause articulation, roll, insertion, retraction, etc.) during navigation.” (emphasis added)(¶ [0006]), “In some embodiments, based on such user input, the system can be configured to automatically, dynamically, and/or algorithmically calculate or determine a pathway for the tool to proceed from one waypoint to another waypoint inputted by the user and cause a surgical robot to advance the tool accordingly. In some embodiments, the system can be configured to utilize one or more machine learning and/or artificial intelligence algorithms to determine a pathway for the tool to advance from one waypoint to another waypoint.” (¶ [0107])).
Referring to claim 2, Sganga discloses the method of claim 1, wherein the intervention device is a guidewire (“Systems, methods, and devices for guiding an instrument within a vascular network of a patient are described herein. In some embodiments, the instrument comprises an endovascular or intraluminal instrument configured for navigation through the vascular network, such as a catheter (including a steerable or articulating catheter), guidewire, sheath, etc. In some embodiments, the instrument is coupled to a robotic medical system that is configured to manipulate the instrument (e.g., cause articulation, roll, insertion, retraction, etc.) during navigation.” (emphasis added)(¶ [0006])).
Referring to claim 3, Sganga discloses the method of claim 2, wherein the at least one movement command is a desired location within the patient of a tip of the guidewire (¶¶ [0007]-[0013] and [0146]-[0148]).
Referring to claim 4, Sganga discloses the method of claim 2, further comprising: obtaining an observed position of the guidewire from the robotic surgical system; and determining the estimated current position of the guidewire based on the observed position (¶¶ [0007]-[0013] and [0146]-[0148]).
Referring to claim 7, Sganga discloses the method of claim 2, wherein the determining determines a series of actuator commands, each actuator command of the series of actuator commands corresponds to a state of the guidewire (“A waypoint for the instrument can be identified, either by the system or from a user input (e.g., selection of a target waypoint relative to the medical image), and the instrument can be moved to the waypoint. This process can be iteratively repeated, in some embodiments, in a closed loop, to guide the instrument through the anatomy.” (¶ [0006])).
Referring to claim 8, Sganga discloses the method of claim 2, further comprising: generating image data displaying the estimated current position of the guidewire within a vessel of the patient (Fig. 2, ¶¶ [0006], [0009], [0058]-[0062], “The systems, methods, and devices described herein can, in some embodiments, utilize medical imaging (e.g., X-ray or others) to facilitate navigation. For example, the instrument can be inserted into the anatomy, and a medical image of the anatomy can be captured. The instrument can be identified within the medical image using, for example, one or more computer vision techniques. A waypoint for the instrument can be identified, either by the system or from a user input (e.g., selection of a target waypoint relative to the medical image), and the instrument can be moved to the waypoint.” (¶ [0006])).
Referring to claim 9, Sganga discloses the method of claim 8, wherein the estimated current position of the guidewire is overlaid on a three-dimensional vessel segmentation (¶¶ [0125], [0137] and [0170]).
Referring to claim 11, Sganga discloses a trained system comprising: processing circuitry (Figs. 10 and 15, ¶¶ [0008] and [0010]) configured to cause the trained system to obtain at least one movement command for an intervention device of a robotic surgical system (¶¶ [0006], [0008]) to a location within a patient, determine at least one actuator command for the robotic surgical system associated with the at least one movement command based on the movement command and an estimated current position of the intervention device, and apply the actuator command to the robotic surgical system (see rejection of claim 1 above and the entire reference).
Referring to claim 12, Sganga discloses the trained system of claim 11, wherein the intervention device is a guidewire (“Systems, methods, and devices for guiding an instrument within a vascular network of a patient are described herein. In some embodiments, the instrument comprises an endovascular or intraluminal instrument configured for navigation through the vascular network, such as a catheter (including a steerable or articulating catheter), guidewire, sheath, etc. In some embodiments, the instrument is coupled to a robotic medical system that is configured to manipulate the instrument (e.g., cause articulation, roll, insertion, retraction, etc.) during navigation.” (emphasis added)(¶ [0006])).
Referring to claim 13, Sganga discloses the trained system of claim 12, wherein the at least one movement command is a desired location within the patient of a tip of the guidewire (¶¶ [0007]-[0013] and [0146]-[0148]).
Referring to claim 17, Sganga discloses the trained system of claim 12, wherein the processing circuitry is configured to cause the trained system to determine a series of actuator commands, each actuator command of the series of actuator commands corresponding to a state of the guidewire (“A waypoint for the instrument can be identified, either by the system or from a user input (e.g., selection of a target waypoint relative to the medical image), and the instrument can be moved to the waypoint. This process can be iteratively repeated, in some embodiments, in a closed loop, to guide the instrument through the anatomy.” (¶ [0006])).
Referring to claim 18, Sganga discloses the trained system of claim 12, wherein the processing circuitry is configured to cause the trained system to generate image data displaying the estimated current position of the guidewire within a vessel of the patient (Fig. 2, ¶¶ [0006], [0009], [0058]-[0062], “The systems, methods, and devices described herein can, in some embodiments, utilize medical imaging (e.g., X-ray or others) to facilitate navigation. For example, the instrument can be inserted into the anatomy, and a medical image of the anatomy can be captured. The instrument can be identified within the medical image using, for example, one or more computer vision techniques. A waypoint for the instrument can be identified, either by the system or from a user input (e.g., selection of a target waypoint relative to the medical image), and the instrument can be moved to the waypoint.” (¶ [0006])).
Referring to claim 19, Sganga discloses the trained system of claim 18, wherein the estimated current position of the guidewire is overlaid on a three-dimensional vessel segmentation (¶¶ [0125], [0137] and [0170]).
Referring to claim 21, Sganga discloses a trained system comprising: means for obtaining at least one movement command for an intervention device of a robotic surgical system to a location within a patient; means for determining at least one actuator command for the robotic surgical system associated with the at least one movement command based on the movement command and an estimated current position of the intervention device; and means for applying the actuator command to the robotic surgical system (see rejection of claim 1 above and the entire reference).
Claim(s) 11-13, 17 and 21 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Jihoon Dkweon (Deep Reinforcement Learning for Guidwire Navigation in Coronary Artery Phantom, which is cited in the Information Disclosure Statement, hereinafter “Jihoon”).
Referring to claim 11, Jihoon discloses a trained system comprising: processing circuitry (Figs. 1(a)-1(b)) configured to cause the trained system (see Section II. Material and Method, “B. Network Setting for Reinforcement Learning” at page 2 and “Algorithm 1 Training Process” at page 5) to obtain at least one movement command for an intervention device of a robotic surgical system (Figs. 1(a)-1(b)) to a location within a patient (“In this study, we propose a deep RL framework for autonomous guidewire navigation in robot-assisted coronary interventions.” (page 2, first column). Thus, the system of Jihoon is capable of guiding a guidewire within a patient), determine at least one actuator command for the robotic surgical system associated with the at least one movement command based on the movement command and an estimated current position of the intervention device, and apply the actuator command to the robotic surgical system (see rejection of claim 1 above and the entire reference).
Referring to claim 12, Jihoon discloses the trained system of claim 11, wherein the intervention device is a guidewire (Fig. 1(b) and Fig. 3).
Referring to claim 13, Jihoon discloses the trained system of claim 12, wherein the at least one movement command is a desired location within the patient of a tip of the guidewire (Fig. 1(b) and Fig. 3).
Referring to claim 17, Jihoon discloses the trained system of claim 12, wherein the processing circuitry is configured to cause the trained system to determine a series of actuator commands, each actuator command of the series of actuator commands corresponding to a state of the guidewire (see Section II and Section III).
Referring to claim 21, Sganga discloses a trained system comprising: means for obtaining at least one movement command for an intervention device of a robotic surgical system to a location within a patient; means for determining at least one actuator command for the robotic surgical system associated with the at least one movement command based on the movement command and an estimated current position of the intervention device; and means for applying the actuator command to the robotic surgical system (see rejection of claim 11 above and the entire reference).
Claim Rejections - 35 USC § 103
In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status.
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
Claim(s) 10 and 20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Sganga et al. in view of Yang et al. (US 2024/0033017, hereinafter “Yang”) and further in view of Kaethner et al. (US 2021/0298772, hereinafter “Kaethner”).
Referring to claims 10 and 20, Sganga discloses the method of claim 1 and “wherein the processor is further configured to, for each of the plurality of steps receive, from a force sensor associated with the instrument, an insertion force measure associated with the execution of the at least one current trajectory command by the robotic medical system, and cause the robotic medical system to stop movement of the instrument or retract the instrument when the insertion force measure exceeds a predetermined insertion force limit” (¶ [0008]). Sganga fails to disclose wherein the actuator command is at least one of a velocity command or a torque command for the actuator.
Referring again to claims 10 and 20, however, in the same field of endeavor, which is a method of guiding a guidewire in a patient, Kaethner discloses “The stroke may, for example, be defined by a user, or the required size of the respective next stroke may be determined by a pre-trained machine-learning algorithm based on image information from the imaging, the behavior of the guidewire with previous strokes, or the values of the torque sensor.” (¶ [0043]). Yang discloses “Measurements of force and/or torque applied to the catheter or guidewire shafts can be used to determine applied force and/or torque above a safety threshold. When an applied force and/or torque exceeds a safety threshold, a warning may be provided to a user. Applied force and/or torque measurements may also be used to provide feedback related to better catheter manipulation and control. Applied force and/or torque measurements may also be used with processed fluoroscopic imaging information to determine or characterize distal tip motion.” (¶ [0154]).
Referring still to claims 10 and 20, in view of Kaethner and Yang’s teaching and the disclosure in paragraph [0008] of Sganga, it would have been obvious to one of ordinary skill in the art, before the effective filing date of the application, to have provided a torque command of the guidewire or catheter to the robotic system of Sganga and monitoring the torque of the guidewire to further improve the effectiveness and safety to the system of Sganga.
Allowable Subject Matter
Claims 5-6 and 14-16 objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to TUAN V NGUYEN whose telephone number is (571)272-5962. The examiner can normally be reached Monday - Friday 8:30 AM - 5:30 PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jackie Ho can be reached at 571-272-4696. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/TUAN V NGUYEN/Primary Examiner, Art Unit 3771